Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSB | P07858 | 1/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.41 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.39 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.39 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.39 |
| ▸ | CTSS | P25774 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14586174 | 1.00 | CTSB (0.49) | CTSBCYP3A4ADRB3ADRA2BADRA2C | |
| SCHEMBL14586524 | 0.94 | CTSB (0.43) | CTSBCYP3A4ADRB3ADRA2BADRA2C | |
| SCHEMBL14586177 | 0.94 | CTSB (0.43) | CTSBCYP3A4ADRB3ADRA2BADRA2C | |
| SCHEMBL14586508 | 0.94 | CTSB (0.43) | CTSBCYP3A4ADRB3ADRA2BADRA2C | |
| SCHEMBL14586173 | 0.94 | CTSB (0.43) | CTSBCYP3A4ADRB3ADRA2BADRA2C | |
| SCHEMBL14586141 | 0.93 | CTSB (0.51) | CTSBCYP3A4ADRB3ADRA2BADRA2C | |
| SCHEMBL14586486 | 0.93 | CTSB (0.51) | CTSBCYP3A4ADRB3ADRA2BADRA2C | |
| SCHEMBL14586537 | 0.93 | CTSB (0.43) | CTSBCYP3A4ADRB3ADRA2BADRA2C | |
| SCHEMBL14586180 | 0.93 | CTSB (0.43) | CTSBCYP3A4ADRB3ADRA2BADRA2C | |
| SCHEMBL14586169 | 0.93 | CTSB (0.52) | CTSBCYP3A4ADRB3ADRA2BADRA2C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7173004-B2 | Macrocyclic isoquinoline peptide inhibitors of hepatitis C virus | BRISTOL-MYERS SQUIBB COMPANY (US) | 2007-02-06 | — | — | US | disclosed |